At the heels of the new Optovue Solix product release, Visionix announces a new multimodal device update with its second-generation VX 650.
VX 650 a next generation screening powerhouse
VX 650 provides unparalleled efficiency with comprehensive anterior and posterior segment data at your fingertips, providing all the data you need for effective patient consultation.
Launched in 2021, the VX 650 is an advanced anterior segment analyzer with retinal imaging. The enhanced wavefront-based aberrometer's "quick mode" and new capture flexibilities can decrease screening time by half, offering improved product efficiency.
An economical option for start-ups
VX 650 offers a cost-effective “comprehensive eye exam suite” for a new or additional location when combined with a compatible refraction system like the Eye Refract. Ease of use and quick staff adoption allows clinicians to confidently delegate the entire data collection process to a technician with minimal training.
Data connectivity and multimodality allow practices to enhance patient education because the clinician can view and review test results through HIPAA-compliant software immediately— at a separate viewing station in another room or office. Proprietary Visionix viewing software allows more effective patient education with various visualizations to supplement in-person or remote consultation.
New VX 650 to be featured at VEE 2023 booth #F2205
The new VX 650 multimodal screener will be available for live demonstrations at Vision Expo East booth #F2205 alongside Visionix USA’s line of next generation eye exam technologies, Optovue OCTs, and Briot/Weco lens finishing platforms. Attendees can also request an ROI consultation to explore ways to grow and scale their practice. ECPs who are skipping VEE are invited to book an online demo or ROI consultation for any Visionix product at: visionix.com/us/virtualdemo